COMPARISON OF WHITE BLOOD-CELL DYSCRASIAS DURING SULFASALAZINE THERAPY OF RHEUMATOID-ARTHRITIS AND INFLAMMATORY BOWEL-DISEASE

被引：16
作者：
CAPELL, HA
PULLAR, T
HUNTER, JA
机构：
[1] GARTNAVEL GEN HOSP,GLASGOW G12 0YN,SCOTLAND
[2] UNIV LEEDS,GEN INFIRM,LEEDS LS1 3EX,W YORKSHIRE,ENGLAND
来源：
DRUGS | 1986年 / 32卷
关键词：
D O I：
10.2165/00003495-198600321-00009
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：44 / 48
页数：5
相关论文
共 9 条
[1]   DRUG-INDUCED BLOOD DISORDERS [J].
DANIELSON, DA ;
DOUGLAS, SW ;
HERZOG, P ;
JICK, H ;
PORTER, JB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (23) :3257-3260
[2]  
HUTCHINSON D, 1983, NEW ZEAL MED J, V96, P520
[3]  
JACOBSON IM, 1984, AM J GASTROENTEROL, V80, P118
[4]   TOXIC EPIDERMAL NECROLYSIS, AGRANULOCYTOSIS AND ERYTHROID HYPOPLASIA ASSOCIATED WITH SULPHASALAZINE [J].
MADDOCKS, JL ;
SLATER, DN .
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 1980, 73 (08) :587-588
[5]   WHICH COMPONENT OF SULPHASALAZINE IS ACTIVE IN RHEUMATOID-ARTHRITIS [J].
PULLAR, T ;
HUNTER, JA ;
CAPELL, HA .
BRITISH MEDICAL JOURNAL, 1985, 290 (6481) :1535-1538
[6]  
SINGLETON JW, 1979, GASTROENTEROLOGY, V77, P870
[7]  
VANDEPETTE JEW, 1984, BMJ, V289, P789
[8]   MULTIPLE HEMATOLOGIC ABNORMALITIES ASSOCIATED WITH SULFASALAZINE [J].
WHEELAN, KR ;
COOPER, B ;
STONE, MJ .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (05) :726-727
[9]  
1943, LANCET, V1, P181
1